# The Procter & Gamble Manufacturing Company – FDA Inspection, Sep 27, 2024

Source: https://www.keypedia.com/records/fda_inspections/the-procter-gamble-manufacturing-company/e84603bc-952b-41c7-8b4e-964e328dafed
Source feed: FDA_Inspections

> FDA inspection 1252187 of The Procter & Gamble Manufacturing Company, September 27, 2024. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1252187
- Company Name: The Procter & Gamble Manufacturing Company
- Inspection Date: 2024-09-27
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 945459 - 2015-09-21
- FDA Inspection 789750 - 2012-07-12
- FDA Inspection 748656 - 2011-10-05
- FDA Inspection 662272 - 2010-05-18

## Related Officers

- [Vaishali J. Patel](https://www.keypedia.com/people/vaishali-j-patel/3d515b84-e0fd-4f96-914c-f7f09e2de307)

Company: https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/3c43b412-e6ef-4be3-a7b2-1a5edfb4ff34

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c